Intervention not reported
Quality of life (QoL) · people with a confirmed diagnosis of advanced renal cell carcinoma (RCC) and an intermediate or poor risk according to the International…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Progression‐free survival (PFS) ‐ Network (subnet 1) included 10 pairwise comparisons ‐ Median · people with a confirmed diagnosis of advanced renal cell carcinoma (RCC) and an intermediate or poor risk according to the International…
1 finding from 1 review
Intervention not reported
IMDC risk group · people with a confirmed diagnosis of advanced renal cell carcinoma (RCC) and a favourable risk according to the International Metastatic…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall survival (OS) ‐ Network (subnet 1) included 5 pairwise comparisons ‐ Median · people with a confirmed diagnosis of advanced renal cell carcinoma (RCC) and a favourable risk according to the International Metastatic…
1 finding from 1 review
Intervention not reported
Serious adverse events · people with a confirmed diagnosis of advanced renal cell carcinoma (RCC) and a favourable risk according to the International Metastatic…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Bleeding: Number of days on which a significant bleeding event occurred3 · People with a haematological disorder
Number of platelet transfusions per participant up to 30 days from study entry · People with a haematological disorder
Intervention not reported
Overall survival · people with non‐rhabdomyosarcoma soft tissue sarcoma
The intervention showed no clear difference in overall survival (high certainty).
1 finding from 1 review
Intervention not reported
Treatment‐related mortality · people with non‐rhabdomyosarcoma soft tissue sarcoma
1 finding from 1 review
Intervention not reported
Disease‐free survival · people with non‐rhabdomyosarcoma soft tissue sarcoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Progression‐free survival · people with non‐rhabdomyosarcoma soft tissue sarcoma
The intervention showed no clear difference in progression‐free survival (high certainty).
1 finding from 1 review
Intervention not reported
Non‐hematologic toxicity grade 3 to 4 · people with non‐rhabdomyosarcoma soft tissue sarcoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · people with non‐rhabdomyosarcoma soft tissue sarcoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Mortality (all cause) Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention may leads to lower mortality (all cause) Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
Periprocedural adverse events · people with chronic ischaemic heart disease and congestive heart failure
1 finding from 1 review
Intervention not reported
Non‐fatal myocardial infarction Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention may leads to lower non‐fatal myocardial infarction Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
Rehospitalisation due to heart failure Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention showed no clear difference in rehospitalisation due to heart failure Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
Arrhythmias Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention may leads to lower arrhythmias Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
Composite MACE Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention showed no clear difference in composite MACE Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
LVEF (%) measured by MRI Long‐term · people with chronic ischaemic heart disease and congestive heart failure
1 finding from 1 review